Achille G. Severgnini and Butterfield Fiduciary Exit 5% Ownership in Royalty Pharma plc (RPRX)

Achille G. Severgnini and Butterfield Fiduciary Administrators Trust Company Limited (formerly R&H Trust Co. (Guernsey) Limited) filed Amendment No. 8 to their Schedule 13D for Royalty Pharma plc (RPRX) on June 16, 2026. The filing serves as an exit statement, as the reporting persons' collective beneficial ownership fell to 21,366,927 Class A Ordinary Shares, representing approximately 4.8% of the company—below the 5% regulatory reporting threshold. The reduction in holdings was driven by a series of open-market sales conducted between April 2, 2026, and June 12, 2026, by sub-funds MGG Strategic and GG Strategic. Sale prices ranged from approximately $49.00 to $56.02 per share. As of June 12, 2026, MGG Strategic directly held 11,281,473 shares, while GG Strategic held 10,085,454 shares. Both reporting persons disclaim beneficial ownership of these shares except to the extent of their pecuniary interest. This filing marks the final amendment to their Schedule 13D for this issuer.